Cellectricon is a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative disease. We are a team of highly experienced neurobiologists, stem cell researchers and engineers, with a proven track record of developing innovative in vitro assays of enhanced translational value for our Clients. We always aim for long-term partnerships with our Clients, based on mutual trust and commitment. Our research services include: • Exploratory proof of concept studies. • Customized assay development. • Phenotypic and target-based screening. • Genomic screening for target ID and target deconvolution efforts. • Improved testing methodologies in lead optimization. • Preclinical compound validation.